Almaden Minerals: Q1 Earnings Snapshot
The Vancouver, British Columbia-based company said it had a loss of 1 cent per share.
The company's shares closed at 15 cents. A year ago, they were trading at 12 cents.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19 minutes ago
- Yahoo
Spirax Group (LON:SPX) Has Announced A Dividend Of £0.489
Spirax Group plc's (LON:SPX) investors are due to receive a payment of £0.489 per share on 14th of November. This makes the dividend yield about the same as the industry average at 2.3%. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. Spirax Group's Projected Earnings Seem Likely To Cover Future Distributions While it is always good to see a solid dividend yield, we should also consider whether the payment is feasible. Prior to this announcement, Spirax Group's dividend made up quite a large proportion of earnings but only 52% of free cash flows. In general, cash flows are more important than earnings, so we are comfortable that the dividend will be sustainable going forward, especially with so much cash left over for reinvestment. Looking forward, earnings per share is forecast to rise by 51.7% over the next year. Assuming the dividend continues along the course it has been charting recently, our estimates show the payout ratio being 54% which brings it into quite a comfortable range. View our latest analysis for Spirax Group Spirax Group Has A Solid Track Record Even over a long history of paying dividends, the company's distributions have been remarkably stable. The dividend has gone from an annual total of £0.669 in 2015 to the most recent total annual payment of £1.65. This implies that the company grew its distributions at a yearly rate of about 9.4% over that duration. The dividend has been growing very nicely for a number of years, and has given its shareholders some nice income in their portfolios. Dividend Growth May Be Hard To Achieve Some investors will be chomping at the bit to buy some of the company's stock based on its dividend history. Unfortunately things aren't as good as they seem. Unfortunately, Spirax Group's earnings per share has been essentially flat over the past five years, which means the dividend may not be increased each year. Our Thoughts On Spirax Group's Dividend Overall, we always like to see the dividend being raised, but we don't think Spirax Group will make a great income stock. The company is generating plenty of cash, but we still think the dividend is a bit high for comfort. Overall, we don't think this company has the makings of a good income stock. Companies possessing a stable dividend policy will likely enjoy greater investor interest than those suffering from a more inconsistent approach. At the same time, there are other factors our readers should be conscious of before pouring capital into a stock. For example, we've picked out 1 warning sign for Spirax Group that investors should know about before committing capital to this stock. Looking for more high-yielding dividend ideas? Try our collection of strong dividend payers. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
19 minutes ago
- Yahoo
Be Sure To Check Out Supreme Plc (LON:SUP) Before It Goes Ex-Dividend
Readers hoping to buy Supreme Plc (LON:SUP) for its dividend will need to make their move shortly, as the stock is about to trade ex-dividend. The ex-dividend date generally occurs two days before the record date, which is the day on which shareholders need to be on the company's books in order to receive a dividend. The ex-dividend date is important as the process of settlement involves at least two full business days. So if you miss that date, you would not show up on the company's books on the record date. Therefore, if you purchase Supreme's shares on or after the 21st of August, you won't be eligible to receive the dividend, when it is paid on the 23rd of September. The company's next dividend payment will be UK£0.034 per share, and in the last 12 months, the company paid a total of UK£0.052 per share. Calculating the last year's worth of payments shows that Supreme has a trailing yield of 2.8% on the current share price of UK£1.86. If you buy this business for its dividend, you should have an idea of whether Supreme's dividend is reliable and sustainable. So we need to investigate whether Supreme can afford its dividend, and if the dividend could grow. We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. Dividends are typically paid from company earnings. If a company pays more in dividends than it earned in profit, then the dividend could be unsustainable. Supreme paid out a comfortable 26% of its profit last year. That said, even highly profitable companies sometimes might not generate enough cash to pay the dividend, which is why we should always check if the dividend is covered by cash flow. Thankfully its dividend payments took up just 27% of the free cash flow it generated, which is a comfortable payout ratio. It's encouraging to see that the dividend is covered by both profit and cash flow. This generally suggests the dividend is sustainable, as long as earnings don't drop precipitously. See our latest analysis for Supreme Click here to see the company's payout ratio, plus analyst estimates of its future dividends. Have Earnings And Dividends Been Growing? Businesses with strong growth prospects usually make the best dividend payers, because it's easier to grow dividends when earnings per share are improving. If earnings decline and the company is forced to cut its dividend, investors could watch the value of their investment go up in smoke. Fortunately for readers, Supreme's earnings per share have been growing at 15% a year for the past five years. Earnings per share are growing rapidly and the company is keeping more than half of its earnings within the business; an attractive combination which could suggest the company is focused on reinvesting to grow earnings further. Fast-growing businesses that are reinvesting heavily are enticing from a dividend perspective, especially since they can often increase the payout ratio later. Many investors will assess a company's dividend performance by evaluating how much the dividend payments have changed over time. Supreme has delivered 24% dividend growth per year on average over the past four years. It's great to see earnings per share growing rapidly over several years, and dividends per share growing right along with it. To Sum It Up Should investors buy Supreme for the upcoming dividend? Supreme has grown its earnings per share while simultaneously reinvesting in the business. Unfortunately it's cut the dividend at least once in the past four years, but the conservative payout ratio makes the current dividend look sustainable. There's a lot to like about Supreme, and we would prioritise taking a closer look at it. So while Supreme looks good from a dividend perspective, it's always worthwhile being up to date with the risks involved in this stock. We've identified 2 warning signs with Supreme (at least 1 which shouldn't be ignored), and understanding these should be part of your investment process. If you're in the market for strong dividend payers, we recommend checking our selection of top dividend stocks. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
19 minutes ago
- Yahoo
JOST Werke SE Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Explore JOST Werke's Fair Values from the Community and select yours JOST Werke SE (ETR:JST) just released its latest quarterly report and things are not looking great. It wasn't a great result overall - while revenue fell marginally short of analyst estimates at €391m, statutory earnings missed forecasts by an incredible 66%, coming in at just €0.45 per share. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. After the latest results, the five analysts covering JOST Werke are now predicting revenues of €1.55b in 2025. If met, this would reflect a huge 25% improvement in revenue compared to the last 12 months. Statutory earnings per share are expected to shrink 7.0% to €2.36 in the same period. Yet prior to the latest earnings, the analysts had been anticipated revenues of €1.64b and earnings per share (EPS) of €2.59 in 2025. It's pretty clear that pessimism has reared its head after the latest results, leading to a weaker revenue outlook and a small dip in earnings per share estimates. View our latest analysis for JOST Werke Despite the cuts to forecast earnings, there was no real change to the €66.00 price target, showing that the analysts don't think the changes have a meaningful impact on its intrinsic value. The consensus price target is just an average of individual analyst targets, so - it could be handy to see how wide the range of underlying estimates is. Currently, the most bullish analyst values JOST Werke at €75.00 per share, while the most bearish prices it at €57.00. With such a narrow range of valuations, the analysts apparently share similar views on what they think the business is worth. Of course, another way to look at these forecasts is to place them into context against the industry itself. The analysts are definitely expecting JOST Werke's growth to accelerate, with the forecast 56% annualised growth to the end of 2025 ranking favourably alongside historical growth of 8.2% per annum over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to grow their revenue at 5.5% per year. Factoring in the forecast acceleration in revenue, it's pretty clear that JOST Werke is expected to grow much faster than its industry. The Bottom Line The biggest concern is that the analysts reduced their earnings per share estimates, suggesting business headwinds could lay ahead for JOST Werke. Regrettably, they also downgraded their revenue estimates, but the latest forecasts still imply the business will grow faster than the wider industry. The consensus price target held steady at €66.00, with the latest estimates not enough to have an impact on their price targets. Keeping that in mind, we still think that the longer term trajectory of the business is much more important for investors to consider. We have forecasts for JOST Werke going out to 2027, and you can see them free on our platform here. You should always think about risks though. Case in point, we've spotted 3 warning signs for JOST Werke you should be aware of, and 1 of them is a bit unpleasant. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
